Etoricoxib Ip Api Intermediate

Etoricoxib is a selective COX-2 (cyclooxygenase-2) inhibitor classified as a non-steroidal anti-inflammatory drug (NSAID). Etoricoxib is universally used for its anti-inflammatory, analgesic, and antipyretic properties. Etoricoxib functions as a selective cyclooxygenase-2 (COX-2) inhibitor, providing effective relief from pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. By blocking the COX-2 enzyme, it reduces the production of prostaglandins, which are the chemical messengers responsible for pain and swelling, while potentially causing fewer stomach problems compared to traditional non-selective NSAIDs. We are leading & trusted Etoricoxib api and intermediate supplier worldwide, offering high-purity Etoricoxib that meets global quality and safety standards, with reliable lead times and global supply capability. About the Company GST Registration Date: Oct 2023 Legal Status of Firm: Limited Company Number of Employees: 101 To 500 People Annual Turnover: > 500 Cr company-description: Scimplify, established in 2023, is dedicated to delivering high-quality chemical solutions for diverse industrial needs. We specialize in Itraconazole Powder, Ketones, and Titanium Dioxide, ensuring reliability and performance in every product. Our commitment to innovation and quality drives us to exceed customer expectations. With a focus on safety and sustainability, we serve industries with precision and care. At Scimplify, we simplify complex chemistry for a better tomorrow.